AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event
News update, Sept. 15, 2020—U.S. regulators paused AstraZeneca’s vaccine trial in the U.S. while the National Institutes of Health (NIH) launches an investigation of its own into a serious side effect in an unnamed patient in Britain. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader […]
Polls Find Many Americans Do Not Want COVID-19 Vaccine as Soon as It’s Licensed
Story Highlights More adults in the U.S. are expressing doubts about the safety of a newly licensed COVID-19 vaccine that might become available this year. The number of poll respondents planning on getting a new coronavirus vaccine as soon as it is FDA approved has fallen from a reported high of 50 to 60 percent […]
COVID-19 Vaccine Mandate Unlikely in Canada Say Health Officials
The government of Canada has signed deals to purchase COVID-19 vaccines from four pharmaceutical companies when their vaccines are approved to be given to the public. According to Canada’s Minister of Public Services and Procurement Anita Anand, the Canadian government has contracts with Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Moderna, Novavax and Pfizer […]
New CDC Data Shows 94 Percent of COVID-19 Death Cases Had Underlying Poor Health Conditions
The U.S. Center for Disease Control and Prevention’s (CDC) Sept. 2 weekly update on COVID-19 mortality in the U.S., which is published by the National Center for Health Statistics (NCHS), reported 170,566 deaths “involving COVID-19” that occurred between Feb. 1, 2020 and Aug. 29, 2020.1 During the same time period there were 1,841,678 deaths from […]
The T-Cell Response to COVID-19 Infections and Immunity
Story Highlights Rapid decline of neutralizing antibodies following COVID-19 infection in some people have led to concerns that immunity to the SARS-CoV-2 virus Is temporary. However, several recent studies have shown a presence of virus-specific T-cells that remain, including among patients with mild or asymptomatic infections. Long-lasting immunity after recovery from COVID-19 infection may be […]
Overweight, Obese Patients Among Highest Number of Hospitalized Coronavirus Patients
Researchers are finding a new trend in who’s being hospitalized and dying from COVID-19. They say people who are overweight or obese make up a high a number of those patients. They’re some of the sickest COVID-19 patients Dr. Diego Maldonado sees at Cleveland Clinic. Around 40 percent of them are obese, which is a […]